Griffith University’s BioSpine team, led by Dr Claudio Pizzolato, has won a coveted place in a health tech accelerator program that drives commercialisation of start-up technologies in the Gold Coast Health and Knowledge Precinct (GCHKP). Dr Pizzolato will join the intensive 14-week LuminaX (LX) program, together with BioSpine Coordinator Kyle Mullholland and with support from […]

A Griffith University and UQ research collab is reshaping our understanding of human biomechanics.

Underlying evolutionary dynamics could play a key role in the replication and progress of the chikungunya virus, a mosquito-borne viral disease.

Young Australian adults aged 18-24 years are more likely to binge drink than any other age group.

A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the Spinal Injury Project team toward human clinical trials.

Cutting-edge research and transformative applications achieves real-world impact.

Griffith researchers have developed a groundbreaking diagnostic tool to?streamline the custom fitting of bionic prosthetic limbs?which usually involve an arduous process of trial and error. 

Griffith University researchers are using cutting-edge equipment to expose and inspire girls to pursue STEM at the university level.

Hope is on the horizon for sick children requiring intravenous canulation to administer medication

An often-overlooked allergic condition, eosinophilic esophagitis or EoE, is at the centre of new research investigating whether a natural seaweed product may reduce the occurrence of symptoms.

A project designed to help screen children and adolescents at risk of Fetal Alcohol Spectrum Disorder (FASD) has been awarded a National Health and Medical Research Council Partnership Grant worth $1.49 million.

A pilot smell clinic has commenced at Griffith’s Gold Coast campus in a bid to gather more data on how microorganisms within the nose can contribute to Alzheimer’s disease.

Two Griffith University-led research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF) worth $2.9 million.

A trio of Griffith University researchers has taken out the top prize at this year’s LuminaX, Australia’s largest healthtech accelerator program, developed and delivered in the Gold Coast Health and Knowledge Precinct. Backed by extensive research, with a vision to be powered by AI,YourTrackhas been developed to track and triage children aged 0-17 years who […]

Two Griffith University research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF) worth a combined $2.7 million.

Calls for more study to be conducted into how microorganisms contribute to the onset and progression of Alzheimer’s disease.

Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.

Following 16 years of development, the Tele-MAST program decreases depression and anxiety in brain tumour survivors, has potential to ease the financial burden to the healthcare system and is now rolling out nationally.